No-Observed-Adverse-Effect Level
"No-Observed-Adverse-Effect Level" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The highest dosage administered that does not produce toxic effects.
| Descriptor ID |
D019055
|
| MeSH Number(s) |
E05.940.600 G07.690.936.750
|
| Concept/Terms |
No-Observed-Adverse-Effect Level- No-Observed-Adverse-Effect Level
- Level, No-Observed-Adverse-Effect
- Levels, No-Observed-Adverse-Effect
- No Observed Adverse Effect Level
- No-Observed-Adverse-Effect Levels
- NOAEL
No-Observed-Effect Level- No-Observed-Effect Level
- Level, No-Observed-Effect
- Levels, No-Observed-Effect
- No Observed Effect Level
- No-Observed-Effect Levels
Acceptable Daily Intake- Acceptable Daily Intake
- Acceptable Daily Intakes
- Daily Intake, Acceptable
- Daily Intakes, Acceptable
- Intake, Acceptable Daily
- Intakes, Acceptable Daily
- Tolerable Daily Intake
- Daily Intake, Tolerable
- Daily Intakes, Tolerable
- Intake, Tolerable Daily
- Intakes, Tolerable Daily
- Tolerable Daily Intakes
|
Below are MeSH descriptors whose meaning is more general than "No-Observed-Adverse-Effect Level".
Below are MeSH descriptors whose meaning is more specific than "No-Observed-Adverse-Effect Level".
This graph shows the total number of publications written about "No-Observed-Adverse-Effect Level" by people in this website by year, and whether "No-Observed-Adverse-Effect Level" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "No-Observed-Adverse-Effect Level" by people in Profiles.
-
Chang DF, Prajna NV, Szczotka-Flynn LB, Benetz BA, Lass JH, O'Brien RC, Menegay HJ, Gardner S, Shekar M, Rajendrababu S, Rhee DJ. Comparative corneal endothelial cell toxicity of differing intracameral moxifloxacin doses after phacoemulsification. J Cataract Refract Surg. 2020 Mar; 46(3):355-359.
-
Bakri SJ, Cameron JD, McCannel CA, Pulido JS, Marler RJ. Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model. Am J Ophthalmol. 2006 Jul; 142(1):162-4.
-
Driscoll CD, Valentine R, Staples RE, Chromey NC, Kennedy GL. Developmental toxicity of diglyme by inhalation in the rat. Drug Chem Toxicol. 1998 May; 21(2):119-36.
-
Rickard LB, Driscoll CD, Kennedy GL, Staples RE, Valentine R. Developmental toxicity of inhaled N-methylformamide in the rat. Fundam Appl Toxicol. 1995 Dec; 28(2):167-76.